Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Bioterrorism -- Ignore unavailable to you. Want to Upgrade?

To: tom pope who wrote (705)	8/19/2003 9:56:36 AM
From: Paul Lee	Respond to of 891

CombiMatrix Names Colonel, ret., Dr. David L. Danley Director, Homeland Security and Defense Programs NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Aug. 19, 2003--Acacia Research Corporation (Nasdaq:CBMX)(Nasdaq:ACTG) announced that Dr. David L. Danley, Colonel (ret.) U.S. Army, has joined CombiMatrix Corporation as its Director, Homeland Security and Defense Programs. Dr. Danley's responsibilities will include all of CombiMatrix's defense related activities, including the joint development of its proprietary products for the detection of biological and chemical warfare agents. Dr. Danley, who retired earlier this month, was Project Manager of the Chemical Biological Medical Systems and Joint Vaccine Acquisition Program for the Department of Defense, where he developed critical new vaccine efforts against smallpox, anthrax, and other deadly agents. His responsibilities included advanced development FDA licensure and fielding of medical products against chemical and biological threat agents and for rapid diagnostic systems. Previously, Dr. Danley served as Commander of the U.S. Army Center for Environmental Health Research, where he started a program to develop and evaluate small, low power sensor technologies for toxic compounds. Dr. Danley also served as the Assistant Program Manager for the Joint Program Office for Biological Defense where he initiated the Department of Defense Joint Vaccine Acquisition Program for the development of biological defense vaccines. Dr. Danley was a pioneer in bringing FDA certification to military medical products. He has interacted extensively and at the highest levels with civilian agencies such as the Food and Drug Administration, the National Institutes of Health, Department of Health and Human Services, the Center for Disease Control and Prevention, and the Department of Homeland Security. "CombiMatrix is pleased to welcome Dr. Danley, whose technical background and expertise with the military will be a tremendous asset as we engage in a number of defense initiatives," said Dr. Amit Kumar, President and Chief Executive Officer. "We look forward to his contributions with our current programs, and we hope to expand the applicability of our platforms for a number of new defense initiatives." "I am excited to have the opportunity to be working with CombiMatrix's chip-based detection technology," said Dr. Danley. "This technology has the potential to meet a number of military needs in the areas of early warning and detection as well as potential therapeutics for acute exposure to biowarfare agents." Dr. Danley retired with the rank of Colonel. His numerous awards and citations include distinguished member of the Army Medical Department Regiment, Legion of Merit and Defense Meritorious Service Medal for the Joint Vaccine Acquisition Program, and the Eli Lilly Award for Graduate Research. Dr. Danley earned a Bachelor of Science degree in biology from Portland State University and a Doctorate in Biological Sciences from Purdue University. Dr. Danley completed a Postdoctoral Fellow in Medical Microbiology and Immunology from the University of California, Davis, School of Medicine.